ELiPSE-1 (NCT05336409) is an ongoing Phase 1, multicenter, open-label clinical trial to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of CNTY-101 in patients with R/R, ...
ELiPSE-1 (NCT05336409) is an ongoing Phase 1, multicenter, open-label clinical trial to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of CNTY-101 in patients with R/R, ...
Raw Story on MSN20h
High on politics? Feds press Green Party presidential candidate on payment to weed churchA Green Party presidential candidate made a $300 payment to the First Church of Cannabis and, understandably, the Federal ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Century Therapeutics (IPSC – Research Report), Intellia Therapeutics (NTLA – Research Report) and Arcellx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback